Real World, Pharmacy-assessed Adherence to New Onset Entresto® (Sacubitril/Valsartan) in Patients...
Heart FailureThis is a multicenter, non-interventional, single arm cohort study with prospective collection of primary data via pharmacists in community pharmacies to describe adherence to sacubitril/valsartan in study patients at the end of the study. Eligible patients with newly prescribed sacubitril/valsartan will be observed in pharmaceutical routine.
Pilot Study of the CoVa™ Monitoring of Patients With Congestive Heart Failure
Congestive Heart FailureThe purpose of this study is to obtain observational data allowing for the preliminary assessment of the utility of a noninvasive physiologic monitor for monitoring of patients with congestive heart failure.
Ventricular Rate Regularization for Improved Quality of Life in Patients With CHF and AF
Congestive Heart FailureAtrial FibrillationSingle center investigator initiated sponsored by Guidant Boston Scientific Corp. to evaluate the benefit of ventricular rate regularization (VRR) in patients with congestive heart failure (CHF) and significant atrial fibrillation (AF) burden.
OPTIMA Bi-ventricular Capture Verification Study
Heart FailureThe purpose of this study is to characterize the morphology (shape) of the intracardiac electrograms(EGM) from patients with a resynchronization therapy device.
Prevalence of Atrial Delay That Would Preclude Optimization of Atrioventricular (AV) Delay in Patients...
Heart FailureThe purpose of this study is to determine the proportion of patients who are undergoing Biventricular (BiV) Implantable Cardioverter Defibrillator (ICD) implantation in whom optimization of atrioventricular (AV) delay is not possible due to prolonged inter-atrial/intra-atrial delay. These patients would benefit from left atrial pacing, and if a significant number of patients fall into this group, it may be beneficial to develop a left atrial lead.
EarlySense Monitoring Device Evaluation on CHF Patients
Congestive Heart FailureCHF patients will be monitored using EarlySense ES-16 device and will simultaneously fill diaries and log their weight daily. The data collected and analyzed by the ES-16 device will be correlated with the CHF status data.
Cardiac Compass With Optivol® to Negate Future Inpatient Re-admissions Through Monitoring in HF...
Heart FailureA research study to determine if heart failure can be medically managed using data collected from cardiac monitoring devices
A Study to Evaluate the Clinical Epidemiology of Patients With Heart Failure (HF) in India
Heart FailureThis non-interventional, prospective, multi-centric, cross-sectional study is aimed to observe clinical practice in India in managing Heart Failure patients & to check one year outcome in HF patients. A total of 5 visits will be conducted during the study. There will be a baseline visit followed by four follow-up visits to assess the outcomes
Study of the Sudden Heart Failure Participant Population in the US
Heart DecompensationAn observational study using data from a large US electronic health record database to find participants hospitalized with ADHF who do not have a concurring heart attack
Influence of Right Ventricular Function on Changes in Exercise Capacity After LVAD
Heart Failure With Reduced Ejection FractionLeft Ventricular Assist DeviceThis is an exploratory project with the purpose to describe the responses of the right ventricle (RV) and gas exchange during exercise in patients scheduled to undergo left ventricular assist device (LVAD) implant. Such information might be used to predict the likelihood of RV failure after LVAD implant. Additionally, although patients that undergo LVAD implantation have improved quality of life and survival, their exercise tolerance (although improved) remains markedly reduced compared to healthy subjects. No studies have used cardiopulmonary stress testing and echocardiography to assess cardiac function and gas exchange with LVAD implantation to determine potential factors responsible for their limited function. The aims of this study are as follows: To assess the impact of right ventricle (RV) dysfunction on functional capacity before and after left ventricular assist device (LVAD) implant To determine if the combined use of preoperative clinical, CPX and echo data can assist in predicting who will meet target improvements in functional capacity after LVAD implant.